|
1
|
Schvartzman JM, Sotillo R and Benezra R:
Mitotic chromosomal instability and cancer: Mouse modelling of the
human disease. Nat Rev Cancer. 10:102–115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hasty P and Montagna C: Chromosomal
rearrangements in cancer: Detection and potential causal
mechanisms. Mol Cell Oncol. 1:e299042014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chatterjee A, Rodger EJ and Eccles MR:
Epigenetic drivers of tumourigenesis and cancer metastasis. Semin
Cancer Biol. 51:149–159. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Obe G, Pfeiffer P, Savage JR, Johannes C,
Goedecke W, Jeppesen P, Natarajan AT, Martínez-López W, Folle GA
and Drets ME: Chromosomal aberrations: Formation, identification
and distribution. Mutat Res. 504:17–36. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Natarajan AT and Palitti F: DNA repair and
chromosomal alterations. Mutat Res. 657:3–7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bignold LP: Mechanisms of
clastogen-induced chromosomal aberrations: A critical review and
description of a model based on failures of tethering of DNA strand
ends to strand-breaking enzymes. Mutat Res. 681:271–298. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mateuca RA, Decordier I and Kirsch-Volders
M: Cytogenetic methods in human biomonitoring: principles and uses.
Methods Mol Biol. 817:305–334. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Musak L, Smerhovsky Z, Halasova E, Osina
O, Letkova L, Vodickova L, Polakova V, Buchancova J, Hemminki K and
Vodicka P: Chromosomal damage among medical staff occupationally
exposed to volatile anesthetics, antineoplastic drugs, and
formaldehyde. Scand J Work Environ Health. 39:618–630. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hagmar L, Stromberg U, Bonassi S, Hansteen
IL, Knudsen LE, Lindholm C and Norppa H: Impact of types of
lymphocyte chromosomal aberrations on human cancer risk: Results
from Nordic and Italian cohorts. Cancer Res. 64:2258–2263. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bonassi S, Norppa H, Ceppi M, Strömberg U,
Vermeulen R, Znaor A, Cebulska-Wasilewska A, Fabianova E, Fucic A,
Gundy S, et al: Chromosomal aberration frequency in lymphocytes
predicts the risk of cancer: Results from a pooled cohort study of
22 358 subjects in 11 countries. Carcinogenesis. 29:1178–1183.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vodicka P, Polivkova Z, Sytarova S, Demova
H, Kucerova M, Vodickova L, Polakova V, Naccarati A, Smerhovsky Z,
Ambrus M, et al: Chromosomal damage in peripheral blood lymphocytes
of newly diagnosed cancer patients and healthy controls.
Carcinogenesis. 31:1238–1241. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vodenkova S, Polivkova Z, Musak L,
Smerhovsky Z, Zoubkova H, Sytarova S, Kavcova E, Halasova E,
Vodickova L, Jiraskova K, et al: Structural chromosomal aberrations
as potential risk markers in incident cancer patients. Mutagenesis.
30:557–563. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Albertson DG, Collins C, McCormick F and
Gray JW: Chromosome aberrations in solid tumors. Nat Genet.
34:369–376. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boffetta P, van der Hel O, Norppa H,
Fabianova E, Fucic A, Gundy S, Lazutka J, Cebulska-Wasilewska A,
Puskailerova D, Znaor A, et al: Chromosomal aberrations and cancer
risk: Results of a cohort study from Central Europe. Am J
Epidemiol. 165:36–43. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li H, Hilmarsen HT, Hossain MB, Björk J,
Hansteen IL, Albin M, Furu Skjelbred C and Broberg K: Telomere
length and LINE1 methylation is associated with chromosomal
aberrations in peripheral blood. Genes Chromosomes Cancer. 52:1–10.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu L, Li S and Stohr BA: The role of
telomere biology in cancer. Annu Rev Pathol. 8:49–78. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hemminki K, Rachakonda S, Musak L,
Vymetalkova V, Halasova E, Försti A, Vodickova L, Buchancova J,
Vodicka P and Kumar R: Telomere length in circulating lymphocytes:
Association with chromosomal aberrations. Genes Chromosomes Cancer.
54:194–196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Heidenreich B and Kumar R: TERT promoter
mutations in telomere biology. Mutat Res. 771:15–31. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maciejowski J and de Lange T: Telomeres in
cancer: Tumour suppression and genome instability. Nat Rev Mol Cell
Biol. 18:175–186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shay JW: Role of telomeres and telomerase
in aging and cancer. Cancer Discov. 6:584–593. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ernst A, Jones DT, Maass KK, Rode A, Deeg
KI, Jebaraj BM, Korshunov A, Hovestadt V, Tainsky MA, Pajtler KW,
et al: Telomere dysfunction and chromothripsis. Int J Cancer.
138:2905–2914. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rossner P, Cerna M, Bavorova H, Pastorkova
A and Ocadlikova D: Monitoring of human exposure to occupational
genotoxicants. Cent Eur J Public Health. 3:219–223. 1995.PubMed/NCBI
|
|
23
|
Cawthon RM: Telomere length measurement by
a novel monochrome multiplex quantitative PCR method. Nucleic Acids
Res. 37:e212009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Heidenreich B, Rachakonda PS, Hosen I,
Volz F, Hemminki K, Weyerbrock A and Kumar R: TERT promoter
mutations and telomere length in adult malignant gliomas and
recurrences. Oncotarget. 6:10617–10633. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hosen I, Rachakonda PS, Heidenreich B, de
Verdier PJ, Ryk C, Steineck G, Hemminki K and Kumar R: Mutations in
TERT promoter and FGFR3 and telomere length in bladder cancer. Int
J Cancer. 137:1621–1629. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kroupa M, Polivkova Z, Rachakonda S,
Schneiderova M, Vodenkova S, Buchler T, Jiraskova K, Urbanova M,
Vodickova L, Hemminki K, et al: Bleomycin-induced chromosomal
damage and shortening of telomeres in peripheral blood lymphocytes
of incident cancer patients. Genes Chromosomes Cancer. 57:61–69.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lemon SC, Roy J, Clark MA, Friedmann PD
and Rakowski W: Classification and regression tree analysis in
public health: Methodological review and comparison with logistic
regression. Ann Behav Med. 26:172–181. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Negrini S, Gorgoulis VG and Halazonetis
TD: Genomic instability-an evolving hallmark of cancer. Nat Rev Mol
Cell Biol. 11:220–228. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gisselsson D: Chromosome instability in
cancer: How, when, and why? Adv Cancer Res. 87:1–29. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gay-Bellile M, Romero P, Cayre A, Véronèse
L, Privat M, Singh S, Combes P, Kwiatkowski F, Abrial C, Bignon YJ,
et al: ERCC1 and telomere status in breast tumours treated with
neoadjuvant chemotherapy and their association with patient
prognosis. J Pathol Clin Res. 2:234–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gardner M, Bann D, Wiley L, Cooper R,
Hardy R, Nitsch D, Martin-Ruiz C, Shiels P, Sayer AA, Barbieri M,
et al: Gender and telomere length: systematic review and
meta-analysis. Exp Gerontol. 51:15–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mayer S, Bruderlein S, Perner S, Waibel I,
Holdenried A, Ciloglu N, Hasel C, Mattfeldt T, Nielsen KV and
Möller P: Sex-specific telomere length profiles and age-dependent
erosion dynamics of individual chromosome arms in humans. Cytogenet
Genome Res. 112:194–201. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nawrot TS, Staessen JA, Gardner JP and
Aviv A: Telomere length and possible link to X chromosome. Lancet.
363:507–510. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kyo S, Takakura M, Kanaya T, Zhuo W,
Fujimoto K, Nishio Y, Orimo A and Inoue M: Estrogen activates
telomerase. Cancer Res. 59:5917–5921. 1999.PubMed/NCBI
|
|
36
|
Misiti S, Nanni S, Fontemaggi G, Cong YS,
Wen J, Hirte HW, Piaggio G, Sacchi A, Pontecorvi A, Bacchetti S and
Farsetti A: Induction of hTERT expression and telomerase activity
by estrogens in human ovary epithelium cells. Mol Cell Biol.
20:3764–3771. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Svenson U, Nordfjall K, Stegmayr B, Manjer
J, Nilsson P, Tavelin B, Henriksson R, Lenner P and Roos G: Breast
cancer survival is associated with telomere length in peripheral
blood cells. Cancer Res. 68:3618–3623. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gramatges MM, Telli ML, Balise R and Ford
JM: Longer relative telomere length in blood from women with
sporadic and familial breast cancer compared with healthy controls.
Cancer Epidemiol Biomarkers Prev. 19:605–613. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Levy T, Agoulnik I, Atkinson EN, Tong XW,
Gause HM, Hasenburg A, Runnebaum IB, Stickeler E, Möbus VJ, Kaplan
AL and Kieback DG: Telomere length in human white blood cells
remains constant with age and is shorter in breast cancer patients.
Anticancer Res. 18:1345–1349. 1998.PubMed/NCBI
|
|
40
|
Pooley KA, Sandhu MS, Tyrer J, Shah M,
Driver KE, Luben RN, Bingham SA, Ponder BA, Pharoah PD, Khaw KT, et
al: Telomere length in prospective and retrospective cancer
case-control studies. Cancer Res. 70:3170–3176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Qu S, Wen W, Shu XO, Chow WH, Xiang YB, Wu
J, Ji BT, Rothman N, Yang G, Cai Q, et al: Association of leukocyte
telomere length with breast cancer risk: Nested case-control
findings from the Shanghai Women's Health Study. Am J Epidemiol.
177:617–624. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shen J, Terry MB, Gurvich I, Liao Y, Senie
RT and Santella RM: Short telomere length and breast cancer risk: A
study in sister sets. Cancer Res. 67:5538–5544. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shen J, Gammon MD, Terry MB, Wang Q,
Bradshaw P, Teitelbaum SL, Neugut AI and Santella RM: Telomere
length, oxidative damage, antioxidants and breast cancer risk. Int
J Cancer. 124:1637–1643. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zheng YL, Ambrosone C, Byrne C, Davis W,
Nesline M and McCann SE: Telomere length in blood cells and breast
cancer risk: Investigations in two case-control studies. Breast
Cancer Res Treat. 120:769–775. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bernadotte A, Mikhelson VM and Spivak IM:
Markers of cellular senescence. Telomere shortening as a marker of
cellular senescence. Aging (Albany NY). 8:3–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xu X, Qu K, Pang Q, Wang Z, Zhou Y and Liu
C: Association between telomere length and survival in cancer
patients: A meta-analysis and review of literature. Front Med.
10:191–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Venkatesan S, Natarajan AT and Hande MP:
Chromosomal instability-mechanisms and consequences. Mutat Res
Genet Toxicol Environ Mutagen. 793:176–184. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tanaka K and Hirota T: Chromosomal
instability: A common feature and a therapeutic target of cancer.
Biochim Biophys Acta. 1866:64–75. 2016.PubMed/NCBI
|
|
49
|
Ennour-Idrissi K, Maunsell E and Diorio C:
Telomere length and breast cancer prognosis: A systematic review.
Cancer Epidemiol Biomarkers Prev. 26:3–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kroupa M, Rachakonda SK, Liska V, Srinivas
N, Urbanova M, Jiraskova K, Schneiderova M, Vycital O, Vymetalkova
V, Vodickova L, et al: Relationship of telomere length in
colorectal cancer patients with cancer phenotype and patient
prognosis. Br J Cancer. 121:344–350. 2019. View Article : Google Scholar : PubMed/NCBI
|
